Ключевые слова:
uterine sarcoma; uterine leiomyoma; multimodal diagnosis; magnetic resonance imaging; histopathology; immunohistochemistry; molecular diagnostics.Библиографические ссылки
1. Al Khuri M. et al. Validating the diagnostic accuracy of an MRI-based scoring system for differentiating benign uterine leiomyomas from leiomyosarcomas. – //Int. J. Gynecol. Cancer. - 2024; 34(7):1027-1033. doi:10.1136/ijgc-2023-005220.
2. Alodaini A.A. et al. Uterine Mesenchymal Tumors: Updates on Pathology, Molecular Landscape, and Therapeutics. - // Medicina. 2024;60(7):1085. doi:10.3390/medicina60071085.
3. De Bruyn C. et al. Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study. - // Ultrasound Obstet Gynecol. 2024;63(5):683-690. doi:10.1002/ uog.27535.
4. Hindman N., Kang S., Fournier L. MRI Evaluation of Uterine Masses for Risk of Leiomyosarcoma: A Consensus Statement. - //Radiology. 2023;306(2):e211658. doi:10.1148/radiol. 211658.
5. International Collaboration on Cancer Reporting. Uterine Ancillary Studies: Non-core dataset guidance. Available at: iccr-cancer.org/datasets/docs/iccr-uterine-ancillary/ (accessed 18.10. 2026).
6. Kim K., Kim S., Ahn T. et al. A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis. - // BMC Cancer. 2023; 23:1215. doi:10.1186/s12885-023-11394-0.
7. Raffone A., Raimondo D., Neola D. et al. Diagnostic accuracy of ultrasound in the diagnosis of uterine leiomyomas and sarcomas. – // J. Minim Invasive Gynecol. - 2024;31(1):28-36. e1. doi:10. 1016/j. jmig.2023.09.013.
8. Ray-Coquard I., Casali P.G., Croce S. et al. ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas. - Int. J. Gynecol Cancer. - 2024;34(10):1499-1521. doi:10.1136/ijgc-2024-005823.
9. WHO Classification of Tumours Editorial Board. Female Genital Tumours. 5th ed. - Lyon: IARC; 2020.
